ANIX•benzinga•March 25, 2025 at 11:51 AM

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines

Summary

Anixa Biosciences signed a letter of intent with VERDI Solutions to develop AI-powered personalized and off-the-shelf cancer vaccines, with U.S. trials planned.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 25, 2025 by benzinga